If a Tiger’s feet were built the same way as a mongoose’s feet, they’d have to be about the size of a hippo’s feet to support the big cat’s weight. But they’re not…
Lees meer..

Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors. The findings center on discovery of signaling molecules that are major players in a biochemical mechanism linking certain actions of B cells to solid tumor growth…
Lees meer..

Rapamycin, a drug that keeps the immune system from attacking transplanted organs, may have another exciting use: fighting Alzheimer’s disease. Rapamycin rescued learning and memory deficits in a mouse model of Alzheimer’s, a team from The University of Texas Health Science Center at San Antonio…
Lees meer..

In ongoing work to identify how genes interact with social environments to impact human health, UCLA researchers have discovered what they describe as a biochemical link between misery and death. In addition, they found a specific genetic variation in some individuals that seems to disconnect that link, rendering them more biologically resilient in the face of adversity…
Lees meer..

An international research team led by Columbia University Medical Center successfully used mouse embryonic stem cells to replace diseased retinal cells and restore sight in a mouse model of retinitis pigmentosa. This strategy could potentially become a new treatment for retinitis pigmentosa, a leading cause of blindness that affects approximately one in 3,000 to 4,000 people, or 1…
Lees meer..

The search for new therapeutic agents is time-consuming and expensive. Pharmaceutical companies may have to screen thousands of compounds for the ability to bind a target molecule before they hit upon a promising drug candidate…
Lees meer..

Scientists have pinpointed how a key hormone helps animals to recognise others by their smell. Researchers at the University of Edinburgh have shown that the hormone vasopressin helps the brain differentiate between familiar and new scents…
Lees meer..

Light Sciences Oncology, Inc. (LSO) announced the achievement of a major milestone in its late-stage clinical development of Aptocine™ (talaporfin sodium) for treatment of solid tumors. LSO’s global Phase 3 trial of Aptocine in metastatic colorectal cancer (MCRC) has reached target enrollment of 450 patients at 52 sites…
Lees meer..

Kinex Pharmaceuticals opened a Phase 2 clinical trial to evaluate the safety and efficacy of KX2-391 in patients with bone-metastatic, castrate-resistant prostate cancer (CRPC) who have not had prior chemotherapy…
Lees meer..

Ferring Pharmaceuticals and Gene Security Network (GSN) announced that they have signed an agreement to conduct a clinical trial of GSN’s advanced preimplantation genetic diagnosis (PGD) technology, Parental Support™. The 11-center U.S…
Lees meer..